$44.99
Description
InnoSpire Essence Compressor Nebulizer System
Essence is part of the InnoSpire family of compressor nebulizer systems from Philips Respironics. It provides fast and efficient aerosol drug delivery in a compressor nebulizer system that’s priced right. With proven SideStream technology.
Quick Overview
- Partnered with proven SideStream technology
- Treatments can take as little as 6 – 8 minutes
- Compact design weighs only 3.3 lbs
- Comes with 1 disposable SideStream
Features
-
Active Venturi system for faster delivery
Essence works efficiently with SideStream nebulizers that feature an active Venturi system and provide air flow in addition to that supplied by the compressor, resulting in faster drug delivery and shorter treatment times. They are easy to use with fewer parts to assemble or clean than other conventional nebulizers. SideStream’s unique design provides consistent delivery of medication time after time.
-
Compact and stylish to blend in at home
The stylish design incorporates a handset docking station, filter and power cord and blends gracefully into the home environment. It is covered by a 5-year warranty and is compliant with the international safety and essential performance standard IEC 60601-1 third edition and its amendments.
Specifications
- Warranty – 5 years
- Mode of operation – Intermittent (30 min. on/30 min. off)
- Maximum pressure – 44 psi
- Treatment time – 6-8 minutes
- Size – 4.2” x 6.5” x 6.5”
- Weight – 3.3 lbs
- Nebulization capacity – 8 ml
- Electrical rating/power – 120V/60Hz, 1.7 Amp
- MMAD – (80%) <5 microns
- Maximum flow rate – 9.4 LPM
- Operating flow rate – 7 LPM @ 10 psi
Includes
- SideStream Disposable Nebulizer – Qty: 1
- Reusable Nebulizers – Qty: 1
- Compressor – Qty: 1
Manufactured by Philips Respironics
REF: 1100312
Only logged in customers who have purchased this product may leave a review.
You may also like…
-
- Out of StockSale!
- • Nebulizers, Philips Respironics
InnoSpire Go Portable Mesh Nebulizer
- $239.00
- Read more
-
Reviews
There are no reviews yet.